BioSpace News Archive

Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle™) product platform, today announced a collaboration with the Dementia Discovery Fund (DDF) to use Bicycle technology for the development of novel therapeutics for neurodegenerative diseases.

The Company will vigorously defend itself against the claim made by Veritas.

Providertech (https://www.providertech.com/) recently announced the release of its CareX automated healthcare communication platform to the Azure Marketplace as part of a new co-sell partnership with Microsoft.

This product will be available in single-use vials of 40mg/2mL and 100mg/5mL.

Fox and Friends “We Built That,” a segment that highlights American entrepreneurs and the companies they have built.

HBI is pleased to announce that its Spotlight Analytics Solution has been selected by CT DSS to help the department better understand the care needs of the Medicaid population served and to improve health outcomes in accordance with their Business Intelligence and Health IT Strategic Plan.

Every dollar captured contributes favorably to the bottom line, especially important for rural hospitals facing thinning margins, declining profitability and higher fixed costs

IT professionals still struggle with patching operating systems and managing shadow IT

Collaboration Marks the First Time a US Lab will Offer Advanced AI-based Biopsy Analysis as a Quality Assurance Service Enhancement to Customers Across the US

Cannassure Therapeutics announces another company milestone as they successfully complete their medical cannabis analytical method development and validation, in accordance with IMCA requirements.